Summary & Overview
HCPCS S5551: Rapid-Acting Insulin (Lispro/Aspart), 5 Units
HCPCS Level II code S5551 denotes a 5-unit dose of most rapid-onset insulin (lispro or aspart). This code matters nationally because rapid-acting insulin doses are central to ambulatory diabetes management, short-term correction of hyperglycemia, and transitional care settings where precise, small-unit dosing is billed separately. Use of a distinct HCPCS Level II code enables payers and providers to track supply-based insulin services outside standard drug billing channels.
Key payers in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise interpretation of the code’s clinical context, typical sites of service, and the administrative role of the code in billing workflows. The publication summarizes benchmarks and coverage considerations where available, notes common billing modifiers, and situates the code within diabetes medication administration practice. The content highlights what to expect when this code appears on claims, how it fits into outpatient and home-based insulin delivery scenarios, and which elements require attention for claims processing. Data not available in the input is explicitly noted where specific payer policy details or related taxonomies are missing.
Billing Code Overview
HCPCS Level II code S5551 describes insulin, most rapid onset (lispro or aspart); 5 units. The service represented is the provision or administration of a small, fixed dose of rapid-acting insulin, typically used for acute glycemic management related to meals or hyperglycemia correction. The service type is medication administration/durable medical supply tied to insulin dosing. The typical site of service is ambulatory settings such as outpatient clinics, physician offices, infusion centers, home health visits, or other outpatient care environments where short-acting insulin doses are supplied or administered.
Clinical & Coding Specifications
Clinical Context
A typical patient receiving S5551 is an adult or pediatric patient with diabetes mellitus requiring a rapid-acting insulin bolus for acute glycemic management. A common scenario is a patient with type 1 diabetes presenting to an outpatient clinic, urgent care, or emergency department with hyperglycemia or preparing for a meal where a short, precise dose of lispro or aspart is administered. The workflow includes patient identification and verification, assessment of blood glucose via point-of-care testing, calculation of dosage based on carbohydrate intake or sliding-scale/correction protocol, medication preparation (drawing 5 units of lispro or aspart), administration via subcutaneous injection or insulin pen, documentation of the lot number and units administered, monitoring for hypoglycemia or local injection reactions for a brief observation period, and recording in the medical record for billing and continuity of care. Typical sites of service include outpatient clinics, primary care offices, endocrinology clinics, urgent care centers, and hospital emergency departments.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier - default | Used when no special circumstance applies to the service. |
| | Increased procedural services | When additional work beyond the typical is required (document medically necessary extra work).